617 results on '"Sankaranarayanan, Rengaswamy"'
Search Results
2. Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial
3. Impact of HPV vaccination on HPV-related oral infections
4. Awareness, perceptions, and choices of physicians pertaining to human papillomavirus (HPV) vaccination in India: A formative research study
5. Evolution of patterns of care for women with cervical cancer in Morocco over a decade
6. Accuracy of high-risk HPV DNA PCR, p16(INK4a) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer
7. Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study
8. Patterns of care of breast cancer patients in Morocco – A study of variations in patient profile, tumour characteristics and standard of care over a decade
9. HPV DNA genotyping, HPV E6*I mRNA detection, and p16INK4a/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study
10. Improving access to cancer care among rural populations in India: Development of a validated tool for health system capacity assessment.
11. Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial
12. Setting up a Breast Cancer Awareness Project in Mumbai: Methodology, Experiences and Challenges
13. Diagnostic performance of automated breast ultrasound and handheld ultrasound in women with dense breasts
14. Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts
15. Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years – updated evidence from Indian follow-up cohort study
16. Durability of clinical performance afforded by self-collected HPV testing: A 15-year cohort study in China
17. Are two doses of human papillomavirus vaccine sufficient for girls aged 15–18 years? Results from a cohort study in India
18. Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition
19. Population-based cancer screening programmes in low-income and middle-income countries: regional consultation of the International Cancer Screening Network in India
20. Tackling cancer burden in low-income and middle-income countries: Morocco as an exemplar
21. Training Future Leaders: Experience from China-ASEAN Cancer Control Training Program
22. Comparative accuracy of Pap smear and HPV screening in Ubon Ratchathani in Thailand
23. Body Mass Index, Tobacco Chewing, Alcohol Drinking and the Risk of Oral Submucous Fibrosis in Kerala, India
24. Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries
25. Cancer early detection program based on awareness and clinical breast examination: Interim results from an urban community in Mumbai, India
26. Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines
27. Thermal Ablation Versus Cryotherapy or Loop Excision to Treat Women Positive for Cervical Precancer on Visual Inspection With Acetic Acid Test: Pilot Phase of a Randomised Controlled Trial
28. Patterns of Care of Breast Cancer Patients in a Rural Cancer Center in Western India
29. Efficacy, safety, and acceptability of thermocoagulation for treatment of cervical intraepithelial neoplasia in a hospital setting in Brazil
30. Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition
31. Clinical trial to implementation: Cost and effectiveness considerations for scaling up cervical cancer screening in low- and middle-income countries
32. World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2–3 and screen-and-treat strategies to prevent cervical cancer
33. Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study
34. Organization and evaluation of a pilot cervical cancer screening program in Morocco
35. Socio-demographic and reproductive determinants of cervical neoplasia in seven sub-Sahara African countries
36. Disparities in time trends of cervical cancer mortality rates in Brazil
37. A pilot study to evaluate home-based screening for the common non-communicable diseases by a dedicated cadre of community health workers in a rural setting in India
38. HPV vaccination: The most pragmatic cervical cancer primary prevention strategy
39. Risk of invasive cancer among women visually screened and colposcopy triaged by trained nurses in rural south India
40. Report from a symposium on catalyzing primary and secondary prevention of cancer in India
41. Status of implementation and organization of cancer screening in The European Union Member States—Summary results from the second European screening report
42. Building resilient cervical cancer prevention through gender-neutral HPV vaccination.
43. Comprehensive Control of Human Papillomavirus Infections and Related Diseases
44. Infrastructure Requirements for Human Papillomavirus Vaccination and Cervical Cancer Screening in Sub-Saharan Africa
45. Effectiveness of cryotherapy for histologically confirmed cervical intraepithelial neoplasia grades 1 and 2 in an Indian setting
46. Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala, India
47. Meta-analysis of the effectiveness of cryotherapy in the treatment of cervical intraepithelial neoplasia
48. Mobile Screening Unit (MSU) for the Implementation of the ‘Screen and Treat’ Programme for Cervical Cancer Prevention In Pune, India
49. Risk stratification and long-term risk prediction of E6 oncoprotein in a prospective screening cohort in China
50. Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.